First phase of enrollment of single device for CCM® and ICD therapy completeMarlton, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- ...

have announced their collaboration on a phase 3 clinical trial to evaluate the effectiveness of Sooma's transcranial direct current stimulation (tDCS) medical device in treating symptoms of major ...

The company anticipates finishing these trials between late 2025 and early ... and potential classification as a Class III ...

Before reaching the market, all medical devices are required to meet stringent efficacy and safety standards. This complex process involves extensive clinical trials, documentation, and compliance ...